TIMP-2 Mediated Inhibition of Angiogenesis

Dong Wan Seo(Dankook University), William G. Stetler‐Stevenson(Center for Cancer Research), Paul T. Wingfield(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Hongmei Li(Kunming University of Science and Technology), Beiyang Wei(National Cancer Institute), Tere Diaz(National Cancer Institute), Rita Salloum(National Cancer Institute), Liliana Guédez(National Cancer Institute)
Cell
July 1, 2003
10.1016/s0092-8674(03)00551-8
Cited by 510

Related Papers

Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k
Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements)
|Gut|2020|332
Autoimmune Chronic Pancreatitis
|The American Journal of Gastroenterology|2004|288
TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase
|Brain Research|1992|282
Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin.
|PubMed|2000|279